{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:45:37Z","timestamp":1789591537774,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","content-domain":{"domain":["ijaaonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.ijantimicag.2013.07.013","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T18:30:15Z","timestamp":1377801015000},"page":"410-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans"],"prefix":"10.1016","volume":"42","author":[{"given":"Florent","family":"Morio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrice","family":"Pagniez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Besse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Gay-andrieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Miegeville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Le Pape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0005","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12281-009-0020-z","article-title":"Rare and emerging Candida species","volume":"3","author":"Johnson","year":"2009","journal-title":"Curr Fungal Infect Rep"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1128\/CMR.00029-06","article-title":"Epidemiology of invasive candidiasis: a persistent public health problem","volume":"20","author":"Pfaller","year":"2007","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0015","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S1473-3099(02)00181-0","article-title":"Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences","volume":"2","author":"Sanglard","year":"2002","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0020","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1128\/EC.00151-07","article-title":"Genotypic evolution of azole resistance mechanisms in sequential Candida albicans isolates","volume":"6","author":"Coste","year":"2007","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0025","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.ijantimicag.2005.12.005","article-title":"Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis","volume":"27","author":"Cernicka","year":"2006","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0030","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1128\/AAC.48.6.2124-2131.2004","article-title":"Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles","volume":"48","author":"Chau","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0035","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/EC.3.6.1639-1652.2004","article-title":"TAC1, transcriptional activator of CDR genes, is a new transcription factor involved in the regulation of Candida albicans ABC transporters CDR1 and CDR2","volume":"3","author":"Coste","year":"2004","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0040","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.1371\/journal.ppat.0030164","article-title":"The transcription factor Mrr1p controls expression of the MDR1 efflux pump and mediates multidrug resistance in Candida albicans","volume":"3","author":"Morschh\u00e4user","year":"2007","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0045","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1128\/EC.3.6.1391-1397.2004","article-title":"Role of Candida albicans transcription factor Upc2p in drug resistance and sterol metabolism","volume":"3","author":"Silver","year":"2004","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0050","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1534\/genetics.105.054767","article-title":"A mutation in Tac1p, a transcription factor regulating CDR1 and CDR2, is coupled with loss of heterozygosity at chromosome 5 to mediate antifungal resistance in Candida albicans","volume":"172","author":"Coste","year":"2006","journal-title":"Genetics"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0055","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1111\/j.1365-2958.2008.06309.x","article-title":"Mutations in the multi-drug resistance regulator MRR1, followed by loss of heterozygosity, are the main cause of MDR1 overexpression in fluconazole-resistant Candida albicans strains","volume":"69","author":"Dunkel","year":"2008","journal-title":"Mol Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0060","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1128\/EC.00103-08","article-title":"A gain-of-function mutation in the transcription factor Upc2p causes upregulation of ergosterol biosynthesis genes and increased fluconazole resistance in a clinical Candida albicans isolate","volume":"7","author":"Dunkel","year":"2008","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0065","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1567-1364.2009.00578.x","article-title":"Antifungal drug resistance mechanisms in fungal pathogens from the perspective of transcriptional gene regulation","volume":"9","author":"Sanglard","year":"2009","journal-title":"FEMS Yeast Res"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0070","doi-asserted-by":"crossref","first-page":"2505","DOI":"10.1093\/jac\/dkq354","article-title":"Persistent Candida albicans colonization and molecular mechanisms of azole resistance in autoimmune polyendocrinopathy\u2013candidiasis\u2013ectodermal dystrophy (APECED) patients","volume":"65","author":"Siikala","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0075","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00438-011-0650-z","article-title":"An MDR1 promoter allele with higher promoter activity is common in clinically isolated strains of Candida albicans","volume":"286","author":"Bruzual","year":"2011","journal-title":"Mol Genet Genomics"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1128\/AAC.01102-09","article-title":"An A643T mutation in the transcription factor Upc2p causes constitutive ERG11 upregulation and increased fluconazole resistance in Candida albicans","volume":"54","author":"Heilmann","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0085","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1128\/JCM.00026-11","volume":"49","author":"McManus","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0090","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diagmicrobio.2009.11.006","article-title":"Screening for amino acid substitutions in the Candida albicans Erg11 protein of azole-susceptible and azole-resistant clinical isolates: new substitutions and a review of the literature","volume":"66","author":"Morio","year":"2010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0095","doi-asserted-by":"crossref","first-page":"e21239","DOI":"10.1371\/journal.pone.0021239","article-title":"Amino acid substitutions at the major insertion loop of Candida albicans sterol 14\u03b1-demethylase are involved in fluconazole resistance","volume":"6","author":"Alvarez-Rueda","year":"2011","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0100","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1093\/jac\/dks186","article-title":"Amino acid substitutions in the Candida albicans sterol \u03945,6-desaturase (Erg3p) confer azole resistance: characterization of two novel mutants with impaired virulence","volume":"67","author":"Morio","year":"2012","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0105","unstructured":"Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of yeasts; approved standard. 3rd ed. Document M27-A3. Wayne, PA: CLSI; 2008."},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.diagmicrobio.2011.03.002","article-title":"Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria","volume":"70","author":"Pfaller","year":"2011","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.drup.2010.09.002","article-title":"Wild-type MIC distributions, epidemiological cutoff values and species-specific clinical breakpoints for fluconazole and Candida: time for harmonization of CLSI and EUCAST broth microdilution methods","volume":"13","author":"Pfaller","year":"2010","journal-title":"Drug Resist Updat"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0120","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1128\/AAC.48.5.1788-1796.2004","article-title":"Mechanisms of azole resistance in petite mutants of Candida glabrata","volume":"48","author":"Brun","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0125","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/jac\/dkm299","article-title":"Decreased susceptibility of Candida albicans to azole antifungals: a complication of long-term treatment in autoimmune polyendocrinopathy\u2013candidiasis\u2013ectodermal dystrophy (APECED) patients","volume":"60","author":"Rautemaa","year":"2007","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0130","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ijantimicag.2008.12.001","article-title":"Triazole-resistant candidaemia following posaconazole exposure","volume":"33","author":"Weiler","year":"2009","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0135","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1099\/00221287-148-4-1061","article-title":"Homozygosity at the Candida albicans MTL locus associated with azole resistance","volume":"148","author":"Rustad","year":"2002","journal-title":"Microbiology"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0140","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1128\/EC.00069-09","article-title":"Functional analysis of cis- and trans-acting elements of the Candida albicans CDR2 promoter with a novel promoter reporter system","volume":"8","author":"Coste","year":"2009","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0145","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1128\/EC.05100-11","article-title":"Functional dissection of a Candida albicans zinc cluster transcription factor, the multidrug resistance regulator Mrr1","volume":"10","author":"Schubert","year":"2011","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2013.07.013_bib0150","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1128\/EC.00215-12","article-title":"Gain-of-function mutations in UPC2 are a frequent cause of ERG11 upregulation in azole-resistant clinical isolates of Candida albicans","volume":"11","author":"Flowers","year":"2012","journal-title":"Eukaryot Cell"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002720?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857913002720?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T16:23:54Z","timestamp":1539447834000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857913002720"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0924857913002720"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.013","relation":{},"ISSN":["0924-8579"],"issn-type":[{"value":"0924-8579","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deciphering azole resistance mechanisms with a focus on transcription factor-encoding genes TAC1, MRR1 and UPC2 in a set of fluconazole-resistant clinical isolates of Candida albicans","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2013.07.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. and the International Society of Chemotherapy. All rights reserved.","name":"copyright","label":"Copyright"}]}}